GETINGE Long Term Debt 2016-2024 | GNGBY
GETINGE long term debt from 2016 to 2024. Long term debt can be defined as the sum of all long term debt fields.
| GETINGE Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $368 |
| 2022 | $406 |
| 2021 | $326 |
| 2020 | $767 |
| 2019 | $686 |
| 2018 | $859 |
| 2017 | $604 |
| 2016 | $1,860 |
| 2015 | $1,898 |
| GETINGE Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | $658 |
| 2024-03-31 | $630 |
| 2023-12-31 | $368 |
| 2023-09-30 | $502 |
| 2023-06-30 | $519 |
| 2023-03-31 | $423 |
| 2022-12-31 | $406 |
| 2022-09-30 | |
| 2022-06-30 | $561 |
| 2022-03-31 | $342 |
| 2021-12-31 | $326 |
| 2021-09-30 | $523 |
| 2021-06-30 | $536 |
| 2021-03-31 | |
| 2020-12-31 | $767 |
| 2020-09-30 | $1,251 |
| 2020-06-30 | $1,279 |
| 2020-03-31 | $1,052 |
| 2019-12-31 | $686 |
| 2019-09-30 | $1,110 |
| 2019-06-30 | |
| 2019-03-31 | $1,166 |
| 2018-12-31 | $859 |
| 2018-09-30 | |
| 2018-06-30 | $1,335 |
| 2018-03-31 | $1,351 |
| 2017-12-31 | $604 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | $1,860 |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | $1,898 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.288B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |